Organon & Co. (OGN) Competitors $9.04 +0.11 (+1.17%) Closing price 03:59 PM EasternExtended Trading$9.01 -0.04 (-0.39%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OGN vs. ELAN, VRNA, RVMD, RGC, ABVX, MRUS, RNA, CYTK, RYTM, and GRFSShould you be buying Organon & Co. stock or one of its competitors? The main competitors of Organon & Co. include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Regencell Bioscience (RGC), Abivax (ABVX), Merus (MRUS), Avidity Biosciences (RNA), Cytokinetics (CYTK), Rhythm Pharmaceuticals (RYTM), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry. Organon & Co. vs. Its Competitors Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Regencell Bioscience Abivax Merus Avidity Biosciences Cytokinetics Rhythm Pharmaceuticals Grifols Organon & Co. (NYSE:OGN) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation. Is OGN or ELAN more profitable? Organon & Co. has a net margin of 11.15% compared to Elanco Animal Health's net margin of 9.68%. Organon & Co.'s return on equity of 163.88% beat Elanco Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Organon & Co.11.15% 163.88% 6.99% Elanco Animal Health 9.68%7.04%3.45% Do analysts prefer OGN or ELAN? Organon & Co. currently has a consensus target price of $17.33, indicating a potential upside of 91.63%. Elanco Animal Health has a consensus target price of $20.00, indicating a potential downside of 8.13%. Given Organon & Co.'s higher probable upside, analysts plainly believe Organon & Co. is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organon & Co. 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50Elanco Animal Health 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 2.91 Do institutionals and insiders believe in OGN or ELAN? 77.4% of Organon & Co. shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 2.0% of Organon & Co. shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer OGN or ELAN? In the previous week, Elanco Animal Health had 5 more articles in the media than Organon & Co.. MarketBeat recorded 11 mentions for Elanco Animal Health and 6 mentions for Organon & Co.. Organon & Co.'s average media sentiment score of 1.01 beat Elanco Animal Health's score of 0.83 indicating that Organon & Co. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organon & Co. 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Elanco Animal Health 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, OGN or ELAN? Organon & Co. has higher revenue and earnings than Elanco Animal Health. Organon & Co. is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganon & Co.$6.40B0.37$864M$2.693.36Elanco Animal Health$4.44B2.44$338M$0.8625.31 Which has more volatility & risk, OGN or ELAN? Organon & Co. has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. SummaryOrganon & Co. beats Elanco Animal Health on 9 of the 17 factors compared between the two stocks. Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGN vs. The Competition Export to ExcelMetricOrganon & Co.Medical Services IndustryMedical SectorNYSE ExchangeMarket Cap$2.32B$8.42B$6.19B$21.90BDividend Yield0.89%2.11%5.72%3.59%P/E Ratio3.3677.7529.6432.78Price / Sales0.3740.78577.4660.02Price / Cash1.8121.1336.5524.20Price / Book4.947.1812.074.65Net Income$864M$250.93M$3.32B$1.01B7 Day Performance-3.57%0.35%-0.16%1.48%1 Month Performance-14.39%-1.96%5.76%0.43%1 Year Performance-47.44%14.71%65.71%12.71% Organon & Co. Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGNOrganon & Co.4.8864 of 5 stars$9.05+1.2%$17.33+91.6%-48.5%$2.32B$6.40B3.364,000News CoveragePositive NewsUpcoming EarningsELANElanco Animal Health2.4471 of 5 stars$20.04+1.4%$19.14-4.5%+70.9%$9.96B$4.48B23.309,000Analyst ForecastVRNAVerona Pharma PLC American Depositary Share1.0908 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.3003 of 5 stars$48.75+1.1%$74.64+53.1%+12.4%$9.11BN/A-10.83250News CoverageAnalyst UpgradeRGCRegencell Bioscience0.6962 of 5 stars$17.99+7.0%N/AN/A$8.90BN/A0.0010ABVXAbivax3.3755 of 5 stars$95.63+2.0%$114.25+19.5%+763.9%$7.23BN/A0.0061Short Interest ↓MRUSMerus1.7392 of 5 stars$94.85+0.5%$93.12-1.8%+77.5%$7.17B$56.23M-17.2537Upcoming EarningsShort Interest ↓RNAAvidity Biosciences2.6313 of 5 stars$48.96-1.6%$68.32+39.5%-1.1%$7.14B$10.90M-13.75190CYTKCytokinetics3.8776 of 5 stars$59.59-0.7%$76.64+28.6%-0.3%$7.13B$85.74M-11.68250Trending NewsAnalyst ForecastInsider TradeRYTMRhythm Pharmaceuticals3.0217 of 5 stars$100.770.0%$106.64+5.8%+122.2%$6.69B$156.29M-33.48140Insider TradeGRFSGrifols3.446 of 5 stars$9.45+1.4%$10.30+9.0%+8.3%$6.50B$7.81B8.0823,822 Related Companies and Tools Related Companies ELAN Alternatives VRNA Alternatives RVMD Alternatives RGC Alternatives ABVX Alternatives MRUS Alternatives RNA Alternatives CYTK Alternatives RYTM Alternatives GRFS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGN) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGN Stock Alerts